News
The initiative is a response to a Trump administration order to speed the construction of the type of new drug factories many ...
“All we can do now is give them trazodone two hours before a storm and try to comfort them,” Cantwell said. Anti-anxiety ...
The U.S. Food and Drug Administration on Thursday announced a new program to strengthen the domestic pharmaceutical supply ...
FDA’s New Priority Voucher Program for Drug Developers Ties Incentives to Defined National Interests
The US Food and Drug Administration recently announced the launch of a regulatory incentive program pilot program, the ...
The U.S. Food and Drug Administration (FDA) on Thursday announced FDA PreCheck, a program developed in response to a recent ...
The FDA accepted vepdegestrant’s new drug application for ER+/HER2–, ESR1-mutated advanced breast cancer with a June 5, 2026, ...
MAXONA Pharmaceuticals today announced that the company has submitted an Investigational New Drug (IND) Application to the ...
4h
pH-D Feminine Health Launches First FDA-Cleared Phase 3 Clinical Trial for Boric Acid Suppositories
H-D Feminine Health, announces it has initiated the first randomized, placebo-controlled, double-blinded Phase 3 clinical trial cleared to proceed by the U.S. Food and Drug Administration (FDA) to ...
The U.S. Food and Drug Administration has approved Insmed's oral drug for a type of lung disease, the company said on Tuesday ...
The US Food and Drug Administration (FDA) recently announced the availability of the first-ever centralized database of Complete Response ...
The U.S. Food and Drug Administration announced Thursday it is launching "FDA PreCheck" in order to help construct drug ...
Submission of New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for GTx-104 Seeking Approval of GTx-104 in the Treatment of Patients with aneurysmal Subarachnoid Hemorrhage (aSAH) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback